# Pembrolizumab-induced oral erosive lichen planus treated with dupilumab

**Authors:** Lisa S. Mun, Ndidi Enwereji, Steven Daveluy

PMC · DOI: 10.1016/j.jdcr.2026.01.027 · 2026-01-29

## Full-text entities

- **Genes:** CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}, IL23A (interleukin 23 subunit alpha) [NCBI Gene 51561] {aka IL-23, IL-23A, IL23P19, P19, SGRF}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}
- **Diseases:** ulcer (MESH:D014456), vitiligo (MESH:D014820), erosions (MESH:D014077), cancer (MESH:D009369), -related cutaneous adverse events (MESH:D002318), drug eruptions (MESH:D003875), lichenoid dermatoses (MESH:D012871), lichenoid eruption (MESH:D017512), inflammation (MESH:D007249), LP (MESH:D008010), keratinocyte injury (MESH:C580062), cutaneous adverse (MESH:D013262), pruritus (MESH:D011537), oral cavity squamous cell carcinoma (MESH:D000077195), dermatitis (MESH:D003872), Eczematous (MESH:D017443)
- **Chemicals:** Pembrolizumab (MESH:C582435), paclitaxel (MESH:D017239), dexamethasone (MESH:D003907), carboplatin (MESH:D016190), lidocaine (MESH:D008012), Dupilumab (MESH:C582203), Prednisone (MESH:D011241), steroid (MESH:D013256), fluconazole (MESH:D015725)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12961208/full.md

---
Source: https://tomesphere.com/paper/PMC12961208